Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Various factors, such as improved medical research, evolving demographics, and advancing healthcare practices influence dynamic market prospects for salivary gland infection. Over the last few years, there has been an observable increase in cases of this disease in the population which has made it a matter of concern to health care professionals. These changes have followed from a change in lifestyle, increased life expectancy among aging population and public awareness about oral health.
Another key trend in the market is a focus on early salivary gland infections detection and diagnosis. The importance of finding out about the disease quickly so as to avoid complications that may be fatal and better patient outcomes have been realized by doctors. Technological advancements such as imaging techniques or molecular testing have been crucial in improving accuracy and timeliness of diagnoses. This move promotes prompt medical intervention while also fueling demand for novel diagnostic solutions within that industry.
Besides, there is a shift towards personalized targeted therapies within the market place. As we understand more about why people get salivary gland infections, clinicians are now tailoring therapeutic interventions according to patient specific profiles. With this approach treatment becomes more effective while reducing unwanted effects hence enhancing patient centeredness in healthcare system improvement efforts. In response to this development among others pharmaceutical companies are spending money on research and coming up with new drugs aimed at tackling salivary gland infections.
Additionally, there exist variations in terms of the prevalence of diseases and healthcare infrastructure across countries regarding global market for salivary gland infection. Salivary gland infection is becoming more widespread especially among developing nations due to population explosions coupled with poor eating habits as well as little access to healthcare facilities (Zhang et al., 2017). So far stakeholders in these territories are considering expanding healthcare facilities alongside educating locals on preventative measures against salivary gland infection (Li & Sunil Kumar Gupta 2018). Such an opportunity would allow marketers work closely with local health care players engaging particular needs of such groups.
Technologically, telemedicine and digital health solutions have become common in managing salivary gland infections. This advancement allows the use of telehealth platforms that involve remote consultations thus making it easier for people to reach doctors when needed or seek advice from them. There is a rising need for virtual care solutions in post-pandemic situations as they are the only way out to provide continuous healthcare delivery. It does not only make patients feel more comfortable avoiding commutes but also contributes to the overall efficiency of health care systems in handling salivary gland infection cases there.
Salivary Gland Infection Market Highlights:
Salivary Gland Infection Market Overview
Salivary Gland Infection Market Size was valued at USD 5.75 Billion in 2023. The Global Salivary Gland Infection industry is projected to grow from USD 6.26 Billion in 2024 to USD 12.39 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.34% during the forecast period (2024 - 2032).
Salivary gland infection is one of the most common medical condition across the globe. These infections are mostly caused due to bacteria or viruses. Salivary gland infection affects salivary duct or gland.
Increasing prevalence of various salivary gland infections, changing disease patterns, and environmental changes are major drivers for the market growth. Rising funding for R&D and clinical trials are leading to improved product development is another key factor for market growth. Improved hygiene practices, growing awareness about self-care and advanced diagnosis and treatment options are important driving forces for the market.
In August 2022, free DNA saliva tests were launched in Australia as one of the first preventive DNA screening programs worldwide for cancer and heart disease risk. It is a nationally collaborative project, led by Australia's Monash University.
In September 2021, Thermo Fisher Scientific launched the Thermo Scientific SpeciMAX Stabilized Saliva Collection Kit, which is designed to collect saliva for research safely. Such initiatives also contribute to the growth of the market.
In June 2022, Goodbody Health Inc. launched four saliva tests that can determine a person's risk of getting cancer or heart disease over ten years via looking at genetics. Such launches are expected to propel the growth of this segment in the future.
LordsMed and Singapore-based diagnostics kit manufacturer Sensing Self have entered into an exclusive partnership to launch one of India's first COVID-19 saliva-based rapid antigen test kits in August 2022.
Eurobio Scientific signed an exclusive distribution contract with Orasure in January 2022 regarding OraQuick commercialization, a saliva self-test. This exclusive contract covers French market and its overseas territories.
However, November of 2022 saw Alembic Pharmaceuticals Ltd stating that generic Glycopyrrolate injection was about to be approved by US health regulators, thereby decreasing salivary flow as well as exudation into airways before operation. Also, according to FDA approval, will be given for Abbreviated New Drug Application (ANDA) on Glycopyrrolate Injection such as single-dose vials ranging from 0.2 mg/1mL up to 0.4mg/2 mL (0 .2mg/ml), etc., including another strength like1mg/5 mL(0 .2mg/ml). Besides or instead of oral preparations, the injection may be co-administered when immediate cholinergic receptor response is needed in adults with gastric ulcers.
LordsMed made an exclusive partnership with Sensing Self, a Singapore-based diagnostics kit manufacturer, to launch one of India's first COVID-19 saliva-based rapid antigen test kits in August 2022.
Study objectives of salivary gland infection market:
- To provide detailed analysis of the salivary gland infection market structure with historical and forecast revenue for the next 6 years of the various segments and sub-segments.
- To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of salivary gland infection market
- To provide analysis of the market with respect to four main geographies and their countries – the Americas, Europe, Asia-Pacific, and Middle East & Africa.
- To provide detailed analysis of the market segmented by diagnosis, treatment, end user, and its sub-segments.
- To provide a detailed analysis of salivary gland infection market mainly based on Value Chain analysis, Porter’s Five Forces, Price analysis, and Supply Chain analysis etc.
- To provide a detailed country level analysis of the market with respect to the current market size and future prospects.
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the salivary gland infection market
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the salivary gland infection market
Intended Audience:
- Salivary gland infection drugs manufacturers
- Salivary Gland Infection drugs and treatment providers
- Hospitals and clinics
- Medical Research laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Salivary Gland Infection Market Segment Insights
Salivary Gland Infection Diagnosis Insights
On the basis of diagnosis which comprises of Plain radiography, sialography, high-resolution ultrasonography, Computed tomography (CT), Magnetic Resonance Imaging (MRI), radionuclide scintigraphy, and others. Sialography is further sub-segmented into CT sialography (ultrafast technique), fluoroscopic/conventional sialography (with or without digital subtraction), and MR sialography.
Salivary Gland Infection Treatment Insights
On the basis of treatment, the market has been segmented into medication, surgery, aspiration, home care, and others. Medication is further sub-segmented into antibiotics and others. Antibiotics are further sub-segmented into dicloxacillin, cephalosporins, clindamycin, and others. Surgery includes removal of part of the parotid salivary gland, removal of all of the parotid salivary gland, removal of the submandibular salivary gland, and others. Home remedies include increased water intake, rest, refraining from smoking, massaging the gland with heat, and others.
Salivary Gland Infection End User Insights
On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.
Salivary Gland Infection Regional Insights
Considering the global scenario of the market, Americas holds the largest market share due to various factors such as increasing number of patients with various salivary gland infections and related disorders. European salivary gland infection market is the second largest where the west European countries are dominating the largest market share. Prevalence of various salivary gland infection is rising in Asia Pacific region. Additionally, increasing healthcare spending and rapidly changing healthcare sector, and government initiatives to improve public health are major growth drivers for Asia Pacific salivary gland infection market. Due to low knowledge of disease and treatments, low-income, and limited access to healthcare facilities, Middle East and Africa (ME&A) is likely to have a limited growth in the market.
Key Companies in the market of Salivary Gland Infection Market include
- AbbVie Inc. (US)
- Allergan (Republic of Ireland)
- AstraZeneca (UK)
- FUJIFILM Holdings Corporation (Japan)
- General Electric Company (US)
- GlaxoSmithKline plc. (UK)
- Johnson & Johnson Services, Inc. (US)
- Merck & Co., Inc. (US)
- Pfizer Inc.(US)
- Siemens Healthcare GmbH (Germany)
The report for Global Salivary Gland Infection Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
